Veradigm | MDRX - Ebitda


Veradigm reported $38.81M in EBITDA for its fiscal quarter ending in September of 2022.





Ebitda Change Date
Alcidion AUD 4.19M 365K Dec/2025
Ambu A/S DKK 271M 10M Mar/2026
Amplifon EUR 141.76M 19.85M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Centene USD 2.56B 3.47B Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 2.86B 56M Mar/2025
Coloplast 2.39B 132M Sep/2025
Computer Programs Systems USD 19.2M 10.52M Dec/2025
Convatec Group USD 286.8M 27.5M Dec/2024
CVS Health USD 5.83B 2.08B Mar/2026
Diasorin EUR 90M 2M Mar/2026
Elevance Health USD 4.21B 2.02B Mar/2026
General Electric Aerospace USD 2.84B 568M Mar/2026
Gulf Medical Proj AED 35.5M 2.9M Mar/2025
Humana USD 2.06B 2.35B Mar/2026
IQVIA Holdings USD 932M 114M Mar/2026
Laboratory Of America USD 605.6M 17.5M Mar/2026
Maximus USD 188.03M 17.61M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Med Life RON 108.31M 30.25M Sep/2025
Molina Healthcare USD 267M 385M Mar/2026
Omnicell USD 44.65M 22.46M Mar/2026
Oriola-kd EUR 9.9M 300K Dec/2025
Owens Minor USD 90.02M 2.15M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Rede D'or Sao Luiz BRL 3.59B 505.3M Mar/2026
Siemens Healthineers EUR 1.11B 83M Dec/2025
Supermax Corporation Bhd MYR -141.38M 42.01M Sep/2025
UnitedHealth USD 9.99B 8.5B Mar/2026
Veeva Systems USD 403.96M 29.17M Mar/2026
Veradigm USD 38.81M 29.61M Sep/2022
Xerox USD 110M 54M Jun/2025